Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global High Potency API, Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 High Potency API Product Introduction
  • 1.2 Market Segments
  • 1.3 Key High Potency API Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global High Potency API Market Size Growth Rate by Type
    • 1.4.2 Synthetic HPAPIs
    • 1.4.3 Biotech HPAPIs
  • 1.5 Market by Application
    • 1.5.1 Global High Potency API Market Size Growth Rate by Application
    • 1.5.2 Oncology
    • 1.5.3 Hormonal Disorders
    • 1.5.4 Glaucoma
    • 1.5.5 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): High Potency API Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the High Potency API Industry
      • 1.6.1.1 High Potency API Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and High Potency API Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for High Potency API Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global High Potency API Market Size Estimates and Forecasts
    • 2.1.1 Global High Potency API Revenue 2015-2026
    • 2.1.2 Global High Potency API Sales 2015-2026
  • 2.2 High Potency API Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global High Potency API Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global High Potency API Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global High Potency API Competitor Landscape by Players

  • 3.1 High Potency API Sales by Manufacturers
    • 3.1.1 High Potency API Sales by Manufacturers (2015-2020)
    • 3.1.2 High Potency API Sales Market Share by Manufacturers (2015-2020)
  • 3.2 High Potency API Revenue by Manufacturers
    • 3.2.1 High Potency API Revenue by Manufacturers (2015-2020)
    • 3.2.2 High Potency API Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global High Potency API Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by High Potency API Revenue in 2019
    • 3.2.5 Global High Potency API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 High Potency API Price by Manufacturers
  • 3.4 High Potency API Manufacturing Base Distribution, Product Types
    • 3.4.1 High Potency API Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers High Potency API Product Type
    • 3.4.3 Date of International Manufacturers Enter into High Potency API Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global High Potency API Market Size by Type (2015-2020)
    • 4.1.1 Global High Potency API Sales by Type (2015-2020)
    • 4.1.2 Global High Potency API Revenue by Type (2015-2020)
    • 4.1.3 High Potency API Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global High Potency API Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global High Potency API Sales Forecast by Type (2021-2026)
    • 4.2.2 Global High Potency API Revenue Forecast by Type (2021-2026)
    • 4.2.3 High Potency API Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global High Potency API Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global High Potency API Market Size by Application (2015-2020)
    • 5.1.1 Global High Potency API Sales by Application (2015-2020)
    • 5.1.2 Global High Potency API Revenue by Application (2015-2020)
    • 5.1.3 High Potency API Price by Application (2015-2020)
  • 5.2 High Potency API Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global High Potency API Sales Forecast by Application (2021-2026)
    • 5.2.2 Global High Potency API Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global High Potency API Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America High Potency API by Country
    • 6.1.1 North America High Potency API Sales by Country
    • 6.1.2 North America High Potency API Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America High Potency API Market Facts & Figures by Type
  • 6.3 North America High Potency API Market Facts & Figures by Application

7 Europe

  • 7.1 Europe High Potency API by Country
    • 7.1.1 Europe High Potency API Sales by Country
    • 7.1.2 Europe High Potency API Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe High Potency API Market Facts & Figures by Type
  • 7.3 Europe High Potency API Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific High Potency API by Region
    • 8.1.1 Asia Pacific High Potency API Sales by Region
    • 8.1.2 Asia Pacific High Potency API Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific High Potency API Market Facts & Figures by Type
  • 8.3 Asia Pacific High Potency API Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America High Potency API by Country
    • 9.1.1 Latin America High Potency API Sales by Country
    • 9.1.2 Latin America High Potency API Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America High Potency API Market Facts & Figures by Type
  • 9.3 Central & South America High Potency API Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa High Potency API by Country
    • 10.1.1 Middle East and Africa High Potency API Sales by Country
    • 10.1.2 Middle East and Africa High Potency API Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa High Potency API Market Facts & Figures by Type
  • 10.3 Middle East and Africa High Potency API Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description, Business Overview and Total Revenue
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer High Potency API Products Offered
    • 11.1.5 Pfizer Recent Development
  • 11.2 Novartis International
    • 11.2.1 Novartis International Corporation Information
    • 11.2.2 Novartis International Description, Business Overview and Total Revenue
    • 11.2.3 Novartis International Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis International High Potency API Products Offered
    • 11.2.5 Novartis International Recent Development
  • 11.3 Sanofi
    • 11.3.1 Sanofi Corporation Information
    • 11.3.2 Sanofi Description, Business Overview and Total Revenue
    • 11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Sanofi High Potency API Products Offered
    • 11.3.5 Sanofi Recent Development
  • 11.4 Boehringer Ingelheim
    • 11.4.1 Boehringer Ingelheim Corporation Information
    • 11.4.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
    • 11.4.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Boehringer Ingelheim High Potency API Products Offered
    • 11.4.5 Boehringer Ingelheim Recent Development
  • 11.5 Bristol-Myers Squibb
    • 11.5.1 Bristol-Myers Squibb Corporation Information
    • 11.5.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
    • 11.5.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Bristol-Myers Squibb High Potency API Products Offered
    • 11.5.5 Bristol-Myers Squibb Recent Development
  • 11.6 Teva Pharmaceutical
    • 11.6.1 Teva Pharmaceutical Corporation Information
    • 11.6.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
    • 11.6.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Teva Pharmaceutical High Potency API Products Offered
    • 11.6.5 Teva Pharmaceutical Recent Development
  • 11.7 Eli Lilly and Company
    • 11.7.1 Eli Lilly and Company Corporation Information
    • 11.7.2 Eli Lilly and Company Description, Business Overview and Total Revenue
    • 11.7.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Eli Lilly and Company High Potency API Products Offered
    • 11.7.5 Eli Lilly and Company Recent Development
  • 11.8 GlaxoSmithKline
    • 11.8.1 GlaxoSmithKline Corporation Information
    • 11.8.2 GlaxoSmithKline Description, Business Overview and Total Revenue
    • 11.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 GlaxoSmithKline High Potency API Products Offered
    • 11.8.5 GlaxoSmithKline Recent Development
  • 11.9 Merck & Co
    • 11.9.1 Merck & Co Corporation Information
    • 11.9.2 Merck & Co Description, Business Overview and Total Revenue
    • 11.9.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Merck & Co High Potency API Products Offered
    • 11.9.5 Merck & Co Recent Development
  • 11.10 AbbVie
    • 11.10.1 AbbVie Corporation Information
    • 11.10.2 AbbVie Description, Business Overview and Total Revenue
    • 11.10.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 AbbVie High Potency API Products Offered
    • 11.10.5 AbbVie Recent Development
  • 11.1 Pfizer
    • 11.1.1 Pfizer Corporation Information
    • 11.1.2 Pfizer Description, Business Overview and Total Revenue
    • 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Pfizer High Potency API Products Offered
    • 11.1.5 Pfizer Recent Development
  • 11.12 Bayer
    • 11.12.1 Bayer Corporation Information
    • 11.12.2 Bayer Description, Business Overview and Total Revenue
    • 11.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Bayer Products Offered
    • 11.12.5 Bayer Recent Development
  • 11.13 Mylan
    • 11.13.1 Mylan Corporation Information
    • 11.13.2 Mylan Description, Business Overview and Total Revenue
    • 11.13.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Mylan Products Offered
    • 11.13.5 Mylan Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 High Potency API Market Estimates and Projections by Region
    • 12.1.1 Global High Potency API Sales Forecast by Regions 2021-2026
    • 12.1.2 Global High Potency API Revenue Forecast by Regions 2021-2026
  • 12.2 North America High Potency API Market Size Forecast (2021-2026)
    • 12.2.1 North America: High Potency API Sales Forecast (2021-2026)
    • 12.2.2 North America: High Potency API Revenue Forecast (2021-2026)
    • 12.2.3 North America: High Potency API Market Size Forecast by Country (2021-2026)
  • 12.3 Europe High Potency API Market Size Forecast (2021-2026)
    • 12.3.1 Europe: High Potency API Sales Forecast (2021-2026)
    • 12.3.2 Europe: High Potency API Revenue Forecast (2021-2026)
    • 12.3.3 Europe: High Potency API Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific High Potency API Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: High Potency API Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: High Potency API Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: High Potency API Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America High Potency API Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: High Potency API Sales Forecast (2021-2026)
    • 12.5.2 Latin America: High Potency API Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: High Potency API Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa High Potency API Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: High Potency API Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: High Potency API Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: High Potency API Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key High Potency API Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 High Potency API Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    High Potency API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global High Potency API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the High Potency API market is segmented into
    Synthetic HPAPIs
    Biotech HPAPIs

    Segment by Application, the High Potency API market is segmented into
    Oncology
    Hormonal Disorders
    Glaucoma
    Other

    Regional and Country-level Analysis
    The High Potency API market is analysed and market size information is provided by regions (countries).
    The key regions covered in the High Potency API market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and High Potency API Market Share Analysis
    High Potency API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in High Potency API business, the date to enter into the High Potency API market, High Potency API product introduction, recent developments, etc.
    The major vendors covered:
    Pfizer
    Novartis International
    Sanofi
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Teva Pharmaceutical
    Eli Lilly and Company
    GlaxoSmithKline
    Merck & Co
    AbbVie
    Johnson & Johnson
    Bayer
    Mylan

    Buy now